Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience.
Section of Infectious Disease and Global Health, Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA.
Department of Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.
- Published Article
Clinical Infectious Diseases
Oxford University Press
- Publication Date
Apr 26, 2021
Community-acquired coinfection in coronavirus disease 2019 (COVID-19) is not well defined. Current literature describes coinfection in 0-40% of COVID-19 patients. In this retrospective report, coinfection was identified in 3.7% of patients and 41% of patients admitted to intensive care (P < .005). Despite infrequent coinfection, antibiotics were used in 69% of patients. © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected]
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 05/08/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/32604413